Literature DB >> 19171015

Disseminated histiocytic sarcoma with peripheral blood involvement in a Bernese Mountain dog.

Silvia Rossi1, Maria Elena Gelain, Stefano Comazzi.   

Abstract

A 6-year-old Bernese Mountain dog was presented with a history of lethargy and weight loss of 2 weeks duration. On physical examination the dog had pale mucous membranes and tachypnea. Ultrasound examination revealed hepatomegaly, splenomegaly, and mesenteric lymphadenomegaly. Results of a CBC included marked normocytic normochromic nonregenerative anemia, marked thrombocytopenia, and moderate leukocytosis with mild neutrophilia and a large population of unclassified round cells (6.2 x 10(3)/microL). The unclassified cells occasionally were bi- or multinucleated and had variably abundant pale basophilic cytoplasm that contained multiple irregular clear vacuoles and occasionally erythrocytes. Fine needle aspirate specimens of the mesenteric lymph nodes and spleen were composed of a population of round pleomorphic cells with the same features as the circulating cells. On flow cytometric analysis of peripheral blood, the unclassified cells expressed CD18, CD45, CD11c, CD1c, and CD14; immunocytochemical analysis of blood smears also indicated the cells were positive for CD1c, CD1a, and CD11c. The dog died a few hours after referral. The histologic interpretation of samples collected from spleen, liver, and lymph nodes was malignant neoplasia of histiocytic origin. Immunohistochemical staining yielded negative results for CD11d, a marker of red-pulp macrophages, ruling out hemophagocytic histiocytic sarcoma. Based on clinical and pathologic findings, the final diagnosis was disseminated histiocytic sarcoma (DHS) with peripheral blood involvement. To our knowledge, DHS in a dog with evidence and immunophenotyping of neoplastic cells in peripheral blood has been reported only rarely.

Entities:  

Mesh:

Year:  2008        PMID: 19171015     DOI: 10.1111/j.1939-165X.2008.00104.x

Source DB:  PubMed          Journal:  Vet Clin Pathol        ISSN: 0275-6382            Impact factor:   1.180


  5 in total

1.  Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.

Authors:  S D Hafeman; D Varland; S W Dow
Journal:  Vet Comp Oncol       Date:  2011-05-18       Impact factor: 2.613

2.  Case report: Haemophagocytic histiocytic sarcoma in an english setter.

Authors:  Mikael Kerboeuf; Hege Brun-Hansen; Malin Oscarson; Heidi Sjetne Lund
Journal:  Vet Med Sci       Date:  2021-03-22

3.  Comparison of the Clinical Characteristics of Histiocytic Sarcoma in Bernese Mountain Dogs and Flat-Coated Retrievers.

Authors:  Suzanne A Erich; Jane M Dobson; Erik Teske
Journal:  Vet Sci       Date:  2022-09-11

4.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17

5.  Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.

Authors:  Atigan Thongtharb; Kazuyuki Uchida; James Kenn Chambers; Yumiko Kagawa; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2015-12-12       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.